A

Amy K. Keating

Boston Children's Hospital

ORCID: 0000-0002-4187-8456

144 papers and 3.7k citations.

PubIndex Score30Top 70% · seniorHow it's scored

144Publications

3.7kTotal Citations

First publication: 1993First senior author: 2010

Top publicationsby citations

MerTK inhibition is a novel therapeutic approach for glioblastoma multiforme

Kristina H. Knubel, Amy K. Keating|Oncotarget|2014

Cited by 60

Indexing the rest of 144 publications…